San Francisco and Asia-based biotechnology company Engine Biosciences has closed a $10-million seed financing round backed by funds affiliated with the Singapore government, according to a corporate press release.
Engine Biosciences uses wet lab experimentation and artificial intelligence (AI) algorithms for drug discovery and cellular reprogramming.
Continue reading this premium story with a subscription to DealStreetAsia.
SubscribeAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
Bring stories like this into your inbox every day.
Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter
